Search Results - "Sennitt, Matthew"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    Effect of high-fat diet on the expression of proteins in muscle, adipose tissues, and liver of C57BL/6 mice by Schmid, Gerhard M., Converset, Véronique, Walter, Nadia, Sennitt, Matthew V., Leung, Kit-Yi, Byers, Helen, Ward, Malcolm, Hochstrasser, Denis F., Cawthorne, Michael A., Sanchez, Jean-Charles

    Published in Proteomics (Weinheim) (01-08-2004)
    “…In the present study, the effect of a high fat diet on the expression of proteins in insulin target tissues was analyzed using a proteomic approach…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Effect of Rosiglitazone on the Differential Expression of Diabetes-associated Proteins in Pancreatic Islets of C57Bl/6 lep/lep Mice by Sanchez, Jean-Charles, Converset, Véronique, Nolan, Anna, Schmid, Gerhard, Wang, Steven, Heller, Manfred, Sennitt, Matthew V, Hochstrasser, Denis F, Cawthorne, Michael A

    Published in Molecular & cellular proteomics (01-07-2002)
    “…The insulin sensitizer drug, rosiglitazone, has been shown to have a protective effect on pancreatic islet cell structure and function in animal models of type…”
    Get full text
    Journal Article
  4. 4

    The mouse SWISS-2D PAGE database: a tool for proteomics study of diabetes and obesity by Sanchez, Jean-Charles, Chiappe, Diego, Converset, Véronique, Hoogland, Christine, Binz, Pierre-Alain, Paesano, Salvo, Appel, Ron D., Wang, Steven, Sennitt, Matthew, Nolan, Anna, Cawthorne, Michael A., Hochstrasser, Denis F.

    Published in Proteomics (Weinheim) (01-01-2001)
    “…A number of two‐dimensional electrophoresis (2‐DE) reference maps from mouse samples have been established and could be accessed through the internet. An…”
    Get full text
    Journal Article
  5. 5

    Effect of rosiglitazone on the differential expression of obesity and insulin resistance associated proteins in lep/lep mice by Sanchez, Jean-Charles, Converset, Véronique, Nolan, Anna, Schmid, Gerhard, Wang, Steven, Heller, Manfred, Sennitt, Matthew V., Hochstrasser, Denis F., Cawthorne, Michael A.

    Published in Proteomics (Weinheim) (01-08-2003)
    “…Peroxisome proliferator‐activated receptors (PPARs) participate in the molecular mechanism of pathologies with altered lipid homeostasis such as type 2…”
    Get full text
    Journal Article
  6. 6

    The effects of rexinoids and rosiglitazone on body weight and uncoupling protein isoform expression in the Zucker fa/fa rat by Emilsson, Valur, O'Dowd, Jacqueline, Wang, Steven, Liu, Yong-Ling, Sennitt, Matthew, Heyman, Richard, Cawthorne, Michael A.

    Published in Metabolism, clinical and experimental (01-12-2000)
    “…Agonists for the retinoid X receptor (RXR), the rexinoids, and the peroxisome proliferator-activated receptor gamma (PPAR γ), the thiazolidinediones, are…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    BRL 35135, a potent and selective atypical β-adrenoceptor agonist by Cawthorne, MA, Sennitt, MV, Arch, JR, Smith, SA

    Published in The American journal of clinical nutrition (01-01-1992)
    “…BRL 35135, via its active deesterified metabolite BRL 37344, is a potent example of a new group of β-adrenoceptor agonists that stimulate selectively a novel β…”
    Get full text
    Journal Article Conference Proceeding
  10. 10

    The selectivity in vitro of the stereoisomers of the beta-3 adrenoceptor agonist BRL 37344 by Oriowo, M A, Chapman, H, Kirkham, D M, Sennitt, M V, Ruffolo, Jr, R R, Cawthorne, M A

    “…The stimulation by BRL 37344 of lipolysis in rat adipose tissues, and of relaxation of the rat distal colon, is mediated by the beta-3 adrenoceptor. The…”
    Get more information
    Journal Article
  11. 11

    The rat lipolytic beta-adrenoceptor: studies using novel beta-adrenoceptor agonists by Wilson, C, Wilson, S, Piercy, V, Sennitt, M V, Arch, J R

    Published in European journal of pharmacology (04-05-1984)
    “…EC50 and relative intrinsic activity values were obtained for isoprenaline, fenoterol, salbutamol, prenalterol and three new beta-adrenoceptor agonists, BRL…”
    Get more information
    Journal Article
  12. 12

    Anti-hyperglycaemic action of BRL 26830, a novel beta-adrenoceptor agonist, in mice and rats by Sennitt, M V, Arch, J R, Levy, A L, Simson, D L, Smith, S A, Cawthorne, M A

    Published in Biochemical pharmacology (15-04-1985)
    “…BRL 26830, (R*,R*)-(+/-)-methyl 4-[2-[(2-hydroxy-2-phenylethyl)amino] propyl] benzoate, is a new orally active anti-hyperglycaemic agent. In 24 hr-fasted rats…”
    Get more information
    Journal Article
  13. 13

    Effects of BRL 26830, a novel beta-adrenoceptor agonist, on glucose tolerance, insulin sensitivity and glucose turnover in Zucker (fa/fa) rats by Smith, S A, Levy, A L, Sennitt, M V, Simson, D L, Cawthorne, M A

    Published in Biochemical pharmacology (15-07-1985)
    “…Zucker fa/fa rats exhibit glucose intolerance in comparison with lean Fa/? littermates. A single acute dose of BRL 26830 (2.9 mg/kg p.o.) improved glucose…”
    Get more information
    Journal Article
  14. 14

    Effect of a novel thermogenic beta-adrenoceptor agonist (BRL 26830) on insulin resistance in soleus muscle from obese Zucker rats by Challiss, R A, Budohoski, L, Newsholme, E A, Sennitt, M V, Cawthorne, M A

    “…Young lean (Fa/?) and obese (fa/fa) rats were treated with the thermogenic beta-adrenoceptor agonist, BRL 26830, for 3 weeks. In lean rats this treatment had…”
    Get more information
    Journal Article